Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,859 papers from all fields of science
Search
Sign In
Create Free Account
ABT 229
Known as:
ABT-229
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Alemcinal
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
[Effect of interstitial cells of Cajal on gastrointestinal motility induced by motilin receptor agonist ABT-229].
Chun-Hui Wang
,
Ling-chao Wang
,
+4 authors
Bao-xi Wang
Zhonghua er ke za zhi = Chinese journal of…
2010
Corpus ID: 24915222
OBJECTIVE To investigate the effect of interstitial cells of Cajal (ICC) on contraction of intestinal tract smooth muscle induced…
Expand
2008
2008
Differences in motilin receptor desensitization after stimulation with motilin or motilides are due to alternative receptor trafficking.
Anna Mitselos
,
P. Vanden Berghe
,
T. Peeters
,
I. Depoortere
Biochemical Pharmacology
2008
Corpus ID: 12118740
2006
2006
The GERD market
Ted T. Ashburn
,
Meera S. Gupta
Nature reviews. Drug discovery
2006
Corpus ID: 20351849
Gastroesophageal reflux disease (GERD) occurs when stomach contents flow into the esophagus. GERD sufferers often complain of a…
Expand
2002
2002
Efficacy of a motilin receptor agonist (ABT‐229) for the treatment of gastro‐oesophageal reflux disease
C. L. Chen
,
W. Orr
,
+8 authors
R. J. Mack
Alimentary Pharmacology and Therapeutics
2002
Corpus ID: 21299957
ABT‐229 is a potent motilin agonist without significant antibiotic activity. It has been shown to improve gastric emptying in…
Expand
2001
2001
Demonstration of a functional motilin receptor in TE671 cells from human cerebellum
L. Thielemans
,
I. Depoortere
,
G. Assche
,
E. Bender
,
T. Peeters
Brain Research
2001
Corpus ID: 19864565
2001
2001
ects of a motilin receptor agonist ( ABT-229 ) on upper gastrointestinal symptoms in type 1 diabetes mellitus : a randomised , double blind , placebo controlled trial
N. Talley
,
M. Verlinden
,
D. Geenen
,
R. B. Hogan
,
R. McCallum
,
R. Mack
2001
Corpus ID: 13920149
Introduction—Erythromycin, a motilin agonist, is a potent prokinetic. ABT-229 is a specific motilin agonist that dose dependently…
Expand
2000
2000
Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin.
S. Sarna
,
A. González
,
R. Ryan
American Journal of Physiology - Gastrointestinal…
2000
Corpus ID: 14303194
We investigated the in vivo and in vitro locus of actions of prokinetics: motilin, erythromycin, and ABT-229. The test substances…
Expand
1999
1999
AN ACTION OF ERYTHROMYCIN IN THE INTESTINE THAT IS NOT MEDIATED VIA MOTILIN RECEPTORS
J. Furness
,
Mj Clark
,
T. Wright
,
P. Bertrand
,
J. Bornstein
,
M. Verlinden
Clinical and Experimental Pharmacology and…
1999
Corpus ID: 35640017
1. Erythromycin lactobionate caused a concentration‐ dependent inhibition of nerve‐mediated contractions of the longitudinal…
Expand
1998
1998
Synthesis of 9-deoxo-4''-deoxy-6,9-epoxyerythromycin derivatives: novel and acid-stable motilides.
R. Faghih
,
P. Lartey
,
+11 authors
J. Plattner
Journal of Medicinal Chemistry
1998
Corpus ID: 25665401
In our quest toward the discovery of highly potent and acid-stable motilides, novel 4"-deoxy derivatives of 9-deoxo-6, 9…
Expand
1996
1996
The safety and pharmacodynamics of a single dose of a new prokinetic macrolide (ABT-229) in healthy adult subjects
Pj Morrison
,
J. Kroodsma
,
R. Koning
,
B. Maes
,
R. Green
,
S. Cox
1996
Corpus ID: 78331467
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE